Park, J., Liu, Y., Lemmon, M., & Radhakrishnan, R. (2012). Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain. Portland Press Ltd.
Chicago Style CitationPark, Jin H., Yingting Liu, Mark A Lemmon, and Ravi Radhakrishnan. Erlotinib Binds Both Inactive and Active Conformations of the EGFR Tyrosine Kinase Domain. Portland Press Ltd, 2012.
MLA CitationPark, Jin H., Yingting Liu, Mark A Lemmon, and Ravi Radhakrishnan. Erlotinib Binds Both Inactive and Active Conformations of the EGFR Tyrosine Kinase Domain. Portland Press Ltd, 2012.
Warning: These citations may not always be 100% accurate.